You are here

Article info

Article menu
Download PDFPDF
Clinical science
Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial

Authors

  • Eric B Suhler Portland Veterans Administration Medical Center, Portland, Oregon, USA.Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USADepartment of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, Oregon PubMed articlesGoogle scholar articles
  • Careen Y Lowder Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles
  • Debra A Goldstein Department of Ophthalmology, University of Illinois-Chicago, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Tracy Giles Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Andreas K Lauer Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Paul A Kurz Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Sirichai Pasadhika Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Shelly T Lee Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Alexandre de Saint Sardos Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Nicholas J Butler Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Howard H Tessler Department of Ophthalmology, University of Illinois-Chicago, Chicago, Illinois, USADepartment of Ophthalmology, Northwestern University, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Justine R Smith Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USADepatment of Cell Biology, Oregon Health & Science University, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • James T Rosenbaum Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USADepatment of Cell Biology, Oregon Health & Science University, Portland, Oregon, USADepartment of Medicine, Oregon Health & Science University, Portland, Oregon, USADevers Eye Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Eric B Suhler, Department of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239-4197, USA; suhlere{at}ohsu.edu
View Full Text

Citation

Suhler EB, Lowder CY, Goldstein DA, et al
Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial
British Journal of Ophthalmology 2013;97:481-486.

Publication history

  • Received August 9, 2012
  • Revised November 28, 2012
  • Accepted January 11, 2013
  • First published February 2, 2013.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions